Breast cancer proliferative activity: Is it the source of serum free DNA?

被引：2

作者：

Hewala, Taha I. ^{[1
]}

El-Moneim, Nadia A. Abd ^{[2
]}

机构：

[1] Alexandria Univ, Med Res Inst, Dept Radiat Sci, 165 Horria Ave,El Hadara, Alexandria 21561, Egypt

[2] Alexandria Univ, Med Res Inst, Dept Canc Management & Res, Alexandria 21561, Egypt

来源：

ALEXANDRIA JOURNAL OF MEDICINE | 2013年 / 49卷 / 04期

关键词：

Breast cancer; Proliferative activity; Diagnosis; Prognosis; DNA; TPS; CEA;

D O I：

10.1016/j.ajme.2013.03.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Aim: To study the relationship between serum DNA and breast cancer proliferative activity, then compare the diagnostic and prognostic values of serum DNA, TPS and CEA. Subjects and methods: A total of 100 breast cancer patients before surgery and 50 apparently healthy controls were analyzed for serum DNA, TPS and CEA. Results: Serum DNA levels were nonsignificantly correlated with serum TPS levels. Serum DNA, TPS and CEA levels were significantly higher in patients than controls. Using ROC curve analysis, serum TPS and DNA had the highest AUC compared to serum CEA. Neither serum TPS, DNA nor CEA correlated with breast cancer clinicopathological data. Only serum CEA was significantly correlated with patients' disease-free survival. Conclusion: Neither Breast cancer mass nor proliferative activity is the source of serum free DNA. Serum TPS is superior to DNA and CEA as a diagnostic marker for breast cancer. Only preoperative serum CEA has a prognostic role in predicting relapse of breast cancer patients, but not serum TPS or DNA. (C) 2013 Production and hosting by Elsevier B.V. on behalf of Alexandria University Faculty of Medicine.

引用

页码：337 / 341

页数：5

共 50 条

[31] Telomerase activity in breast cancer: A significant correlation with tumor proliferative fraction (TPF)
Sahin, A
Bednarek, A
Ordonez, N
Johnston, D
Aldaz, C
LABORATORY INVESTIGATION, 1997, 76 (01) : 125 - 125
[32] Tissue Microarray Technique in Evaluation of Proliferative Activity in Invasive Ductal Breast Cancer
Kobierzycki, Christopher
Pula, Bartosz
Wojnar, Andrzej
Podhorska-Okolow, Marzena
Dziegiel, Piotr
ANTICANCER RESEARCH, 2012, 32 (03) : 773 - 777
[33] PROLIFERATIVE ACTIVITY AND ESTROGEN-RECEPTOR IN HUMAN PRIMARY BREAST-CANCER
CONTE, PF
ALAMA, A
FAVONI, R
FRASCHINI, G
DREWINKO, B
BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 (03) : 306 - 306
[34] Circulating cell-free DNA in serum as a marker for the early detection of tumor recurrence in breast cancer patients
Bera, A.
Eidelman, O.
Russ, E.
Landa, A.
Karaian, J.
Eklund, M.
Hu, H.
Pollard, H. B.
Shriver, C. D.
Srivastava, M.
CANCER RESEARCH, 2019, 79 (04)
[35] Genomic instability and proliferative activity as risk factors for distant metastases in breast cancer
L Li
K Mu
G Zhou
L Lan
G Auer
A Zetterberg
British Journal of Cancer, 2008, 99 : 513 - 519
[36] PLOIDY AND PROLIFERATIVE ACTIVITY BY FLOW-CYTOMETRY IN PRIMARY BREAST-CANCER
FRASCHINI, G
RABER, MN
JOHNSON, TS
GALLAGER, HS
BARLOGIE, B
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1983, 19 (02): : R7 - R7
[37] Genomic instability and proliferative activity as risk factors for distant metastases in breast cancer
Li, L.
Mu, K.
Zhou, G.
Lan, L.
Auer, G.
Zetterberg, A.
BRITISH JOURNAL OF CANCER, 2008, 99 (03) : 513 - 519
[38] Proliferative Activity in Libyan Breast Cancer with Comparison to European and Central African Patients
Boder, Jamela
Abdalla, Fathi
Elfagieh, Mohamed
Buhmeida, Abdelbaset
Collan, Yrjo
BIOMED RESEARCH INTERNATIONAL, 2013, 2013
[39] Fluorimetry as a new approach for detection of proliferative activity and hormonal status of breast cancer
Korneva, Y.
Maryakhina, V.
Dorosevich, A.
Schisterova, O.
VIRCHOWS ARCHIV, 2018, 473 : S200 - S200
[40] Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer
Lei Zhang
Xinyun Song
Xiaoxia Wang
Yuntao Xie
Zengwu Wang
Ye Xu
Xin You
Zicai Liang
Huiqing Cao
Breast Cancer Research and Treatment, 2015, 152 : 199 - 208

← 1 2 3 4 5 →